Passage Bio
PASG----
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: Passage Bio(PASG) predict that the EBIT is -8.247 M (+49.89%), Beat estimate;the EPS is -2.36 (+52.8%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
TBA--
0.00B--
----
EBITExceed expectations
-0.01B49.89%
-0.01B38.90%
+0.00B10.99%
EPSExceed expectations
-2.3652.80%
-2.746.00%
+0.34006.80%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf